Transfusion reactions: A comparative observational study of blood components produced before and after implementation of semiautomated production from whole blood

Transfusion

Volumn 52, Issue 12, 2012, Pages 2683-2691

  Semple, Elisabeth ^a,b,c,d   Bowes Schmidt, Audrey ^a,b,c,d   Yi, Qi Long ^a,b,c,d   Shimla, Susan ^a,b,c,d   Devine, Dana V ^a,b,c,d  

^a CANADIAN BLOOD SERVICES   (Canada)

^b Canadian Blood Services   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GLUCOSE; MANNITOL; SODIUM CHLORIDE;

ANAPHYLAXIS; ARTICLE; BACTERIUM CONTAMINATION; BLOOD BUFFY COAT; BLOOD COMPONENT; BLOOD TRANSFUSION REACTION; CANADA; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROCYTE; HEMATOLOGICAL PROCEDURE; HUMAN; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEMIAUTOMATED PRODUCTION; THROMBOCYTE; THROMBOCYTE RICH PLASMA;

BLOOD BANKS; BLOOD BUFFY COAT; BLOOD COMPONENT REMOVAL; BLOOD GROUP INCOMPATIBILITY; BLOOD PRESERVATION; BLOOD SAFETY; BLOOD TRANSFUSION; CANADA; DATABASES, FACTUAL; ERYTHROCYTES; HUMANS; INCIDENCE; PLATELET-RICH PLASMA; RETROSPECTIVE STUDIES; RISK MANAGEMENT;

EID: 84870986632     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03752.x     Document Type: Article

References (27)

1. Roback JD, Grossman BJ, Harris T, Hillyer C, editors. AABB technical manual. 17th ed. Bethesda (MD): American Association of Blood Banks; 2011.
2. Siegenthaler MA, Schneider P, Vu DH, Tissot JD,. Haemovigilance in a general university hospital: need for a more comprehensive classification and a codification of transfusion-related events. Vox Sang 2005; 88: 22-30.
3. Lin Y, Saw CL, Hannach B, Goldman M,. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services. Transfusion 2012; 52: 567-74.
4. Hebert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, Heddle N, Germain M, Goldman M, Toye B, Schweitzer I, vanWalraven C, Devine D, Sher GD,. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003; 289: 1941-9.
5. Goodnough LT, Riddell JT, Lazarus H, Chafel TL, Prince G, Hendrix D, Yomtovian R,. Prevalence of platelet transfusion reactions before and after implementation of leukocyte-depleted platelet concentrates by filtration. Vox Sang 1993; 65: 103-7.
6. Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG,. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993; 33: 794-7.
7. Oksanen K, Ebeling F, Kekomaki R, Elonen E, Sahlstedt L, Volin L, Myllyla G,. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat. Vox Sang 1994; 67: 356-61.
8. Yazer MH, Podlosky L, Clarke G, Nahirniak SM,. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004; 44: 10-5.
9. Anderson NA, Gray S, Copplestone JA, Chan DC, Hamon M, Prentice AG, Johnson SA, Phillips M, van Waeg G, Oakhill A, Abeyasekera S, Pamphilon DH,. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions. Transfus Med 1997; 7: 33-9.
10. Muylle L, Wouters E, Peetermans ME,. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996; 36: 886-90.
11. Levin E, Culibrk B, Gyongyossy-Issa MI, Weiss S, Scammell K, LeFresne W, Jenkins C, Devine DV,. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Transfusion 2008; 48: 2331-7.
12. Serrano K, Scammell K, Weiss S, Culibrk B, Levin E, Gyongyossy-Issa M, Devine DV,. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards. Transfusion 2010; 50: 344-53.
13. Sheffield WP, Bhakta V, Jenkins C, Devine DV,. Conversion to the buffy coat method and quality of frozen plasma derived from whole blood donations in Canada. Transfusion 2010; 50: 1043-9.
14. Devine DV, Howe D,. Processing of whole blood into cellular components and plasma. ISBT Sci Ser 2010; 5: 78-82.
15. Devine DV, Serrano K,. Preparation of blood products for transfusion: is there a best method? Biologicals 2012; 40: 187-90.
16. Canadian Blood Services. Customer Letter #2005-03 Buffy Coat Production Method. Ottawa, ON, Canada: Canadian Blood Services, 2005. [cited 2012 May 4]. Available from: URL: http://blood.ca/CentreApps/Internet/UW-V502-MainEngine.nsf/ resources/Customer+Letters/$file/CL-2005-03-%282005-05-26%29-ENG.pdf
17. Jenkins C, Ramirez-Arcos S, Goldman M, Devine DV,. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011; 51: 2555-65.
18. Public Health Agency of Canada. Transfusion Transmitted Injuries Surveillance System-User's Manual. 2007. [cited 2011 Oct 27]. Available from: URL: http://www.phac-aspc.gc.ca/hcai-iamss/tti-it/pdf/users-manual-07-e.pdf
19. Vassallo RR, Murphy S,. A critical comparison of platelet preparation methods. Curr Opin Hematol 2006; 13: 323-30.
20. Murphy S,. Platelets from pooled buffy coats: an update. Transfusion 2005; 45: 634-9.
21. Dunbar NM, Walsh SJ, Maynard KJ, Szczepiorkowski ZM,. Transfusion reaction reporting in the era of hemovigilance: where form meets function. Transfusion 2011; 51: 2583-7.
22. Tobian AA, Savage WJ, Tisch DJ, Thoman S, King KE, Ness PM,. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011; 51: 1676-83.
23. Savage WJ, Tobian AA, Fuller AK, Wood RA, King KE, Ness PM,. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. Transfusion 2011; 51: 1716-22.
24. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG,. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331: 625-8.
25. Pruss A, Kalus U, Radtke H, Koscielny J, Baumann-Baretti B, Balzer D, Dorner T, Salama A, Kiesewetter H,. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Transfus Apher Sci 2004; 30: 41-6.
26. Funk MB, Guenay S, Lohmann A, Henseler O, Heiden M, Hanschmann KM, Keller-Stanislawski B,. Benefit of transfusion-related acute lung injury risk-minimization measures-German haemovigilance data (2006-2010). Vox Sang 2012; 102: 317-23.
27. Flesch BK, Petershofen EK, Bux J,. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine. Tissue Antigens 2011; 78: 1-7.